Neurology
Genetic studies can help to correctly diagnose patients with hereditary neurological diseases such as movement disorders, neuromuscular disorders, intellectual disability or epilepsy, among others.
Home » Neurology
Clinical areas
Broader studies
Documentation
- EDTA blood (1x 5 ml)
- Saliva (specific Isohelix kit)
- Buccal exudate (2x sterile isopes)
- gDNA (>30 ng/μl in >100 μl TE buffer)
Remember to label each sample with the patient's first and last name or with the identifier used on the request form.
Movement disorders
The term 'movement disorders' refers to a group of nervous system conditions that cause an increase in abnormal movements, which may be voluntary or involuntary. Movement disorders can also cause slow or reduced movements. We offer the study of the main movement disorders such as dystonia and Parkinson's disease.
Studies included
Parkinson's disease
DG Parkinson (15 genes)
Adult-onset Parkinson's disease (6 genes)
Early-onset Parkinson's disease (9 genes)
Parkinsonian disorders
DG Parkinsonian Disorders (23 genes)
ATP13A2, ATP6AP2, COQ2, DCTN1, FBXO7, GCH1, GRN, LRRK2, LYST, MAPT, OPA1, OPA3, PLA2G6, PTRHD1, RAB39B, SNCA, SPG11, SYNJ1, TWNK, UQCRC1, VPS13A, VPS13C, ZFYVE26.
Dystonia
DG Dystonia (123 genes)
Isolated Dystonia (9 genes)
Dystonia with Parkinsonism (14 genes)
Myoclonic Dystonia (2 gen)
Paroxysmal Dystonia with other dyskinesia (5 genes)
Complex Dystonia (72 genes)
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Dementia
Dementia is an umbrella term that describes a wide range of symptoms associated with memory impairement and other thinking skills, leading to a reduction in a person's ability to carry out daily activities. Alzheimer's disease accounts for 60-80% of cases. The study of genes associated with different types of dementia is included.
Studies included
DG Dementia (30 genes)
Alzheimer's disease (8 genes)
Semantic Dementia (5 genes)
Frontotemporal Dementia (21 genes)
Frontotemporal Dementia and/or ALS (9 genes)
Frontotemporal dementia and/or ALS. C9orf72 Expansion (1 gene) (TP-PCR)
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Neuromuscular diseases
Neuromuscular diseases are a group of more than 150 progressive and chronic neurological conditions, mostly of genetic origin, which cause loss of muscle strength and associated muscle and nerve degeneration. Through the different panels we address the study of various neuromuscular diseases such as neuropathies, myopathies and muscular dystrophies, diseases with motor neuron involvement and myasthenic syndromes as well as other syndromes with hypotonia, myotonia and/or weakness.
Studies included
Motor neurone disease
DG Motoneuron (90 genes)
ALS (Amyotrophic Lateral Sclerosis) (41 genes)
Spinal Muscular Atrophy (2 genes) (MLPA)
Frontotemporal Dementia and/or ALS (9 genes)
Frontotemporal dementia and/or ALS. C9orf72 Expansion (1 gene) (TP-PCR)
Neuropathies
DG Neuropathy (214 genes)
Charcot-Marie-Tooth disease (103 genes)
Motor Neuropathy (43 genes)
Sensitive Neuropathy (17 genes)
Congenital Myasthenia
DG Congenital Myasthenia (37 genes)
Myopathies
DG Myopathies (275 genes)
Muscular dystrophies
Muscular Dystrophy (83 genes)
Facioscapulohumeral dystrophy (6 genes)
Dystrophinopathy (Duchenne and Becker) (1 gene) (MLPA)
DMD.
Dystrophinopathy (Duchenne and Becker) (1 gene)
DMD.
Limb-girdle Muscular Dystrophy (35 genes)
Oculopharyngeal Muscular Dystrophy (1 gene) (TP-PCR)
Emery-Dreifuss dystrophy (7 genes)
Myotonic Dystrophy (2 genes) (TP-PCR)
Distal Myopathy (37 genes)
Congenital myopathies
Congenital Myopathy (66 genes)
Nemaline Myopathy (13 genes)
Central core myopathy (4 genes)
Metabolic Myopathy (120 genes)
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Leukodystrophies
Studies included
The leukodystrophies represent a heterogeneous group of hereditary degenerative diseases of cerebral myelin that produce extensive white matter involvement. The clinical manifestations are very varied, which makes diagnosis difficult.
DG Leukodystrophy and hereditary leukoencephalopathies (145 genes)
Infantile leukodystrophy (88 genes)
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Spastic paraparesis
Hereditary spastic paraparesis (HSP) comprises a genetically and clinically heterogeneous group of neurodegenerative disorders whose predominant signs and symptoms are weakness and spasticity of the lower extremities. We offer different approaches for the study of various types of spastic paraparesis, as well as a general panel including 100 genes associated with the pathology.
Studies included
DG Spastic Paraparesis (100 genes)
Spastic Paraparesis AD Complex (10 genes)
Spastic Paraparesis AD Pure (17 genes)
Complex AR Spastic Paraparesis (58 genes)
Spastic Paraparesis AR Pure (12 genes)
X-Linked Spastic Paraparesis (3 genes)
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Epilepsy
Epilepsy is a disorder of the central nervous system in which normal brain activity is disturbed, causing seizures or periods of unusual behaviour and sensations, and even loss of consciousness. The underlying causes are multiple and heterogeneous. Through different studies we analyse various epilepsy phenotypes. We also include a specific panel for the study of epileptic syndromes of neonatal and infantile onset, as well as a general panel for more complex cases.
Studies included
DG Epilepsy (244 genes)
Neonatal and Childhood Epilepsy (150 genes)
Epileptic Encephalopathy (147 genes)
Generalized Epilepsy (19 genes)
Generalized epilepsy with febrile seizures plus (12 genes)
Focal Epilepsy (35 genes)
Myoclonic Epilepsy (60 genes)
Infantile and Juvenile Myoclonic Epilepsy (10 genes)
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Autism spectrum disorder
Autism Spectrum Disorders (ASD) are defined as a chronic neurological dysfunction that can manifest itself through a series of symptoms related to social interaction, communication and lack of flexibility in reasoning and behavior. The complexity of the clinical manifestations suggests a multicausal etiology with genetic alterations being the main cause. By means of a targeted exome we analyzed 423 genes with a proven association with ASD.
Studies included
DG Autistic Spectrum Disorder (423 genes)
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Intellectual disability
Intellectual disability refers to a group of cognitive disorders of heterogeneous and complex cause with a genetic component in most cases. Advances in genetics have increased the diagnostic rate of current studies by up to 30-40% of patients. Our targeted exome analyzes 588 genes associated with intellectual disability.
Studies included
DG Intellectual Disability (588 genes)
X-linked Intellectual Disability (130 genes)
Fragile X Syndrome (1 gene) (TP-PCR)
Angelman Syndrome (MS-MLPA)
Prader-Willi Syndrome (MS-MLPA)
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Ataxia
Ataxia is a motor disorder characterized by a decreased ability to coordinate movements, manifesting as tremor of body parts during voluntary movements, difficulty in making precise movements or difficulty in maintaining balance.
Studies included
DG Ataxias (176 genes)
DG Episodic Ataxia (8 genes)
Spinocerebellar Ataxia (40 genes)
Spinocerebellar Ataxia without Axonal Neuropathy (6 genes)
Spinocerebellar Ataxia with Axonal Neuropathy (7 genes)
Spinocerebellar Ataxia due to expansion.types SCA1, SCA2, SCA3, SCA6, SCA7 (5 genes) (TP-PCR)
Friedreich's ataxia (1 gene) (TP-PCR)
FXN.
Ataxia-telangiectasia (1 gene)
Fragile X-associated tremor/Ataxia syndrome (1 gene) (TP-PCR)
FMR1.
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days